UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038938
Receipt number R000044406
Scientific Title Development of a predictive strategy for the detection of the patients with high risk for delirium
Date of disclosure of the study information 2020/01/24
Last modified on 2022/09/14 16:38:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a predictive strategy for the detection of the patients with high risk for delirium

Acronym

Deep Study

Scientific Title

Development of a predictive strategy for the detection of the patients with high risk for delirium

Scientific Title:Acronym

Deep Study

Region

Japan


Condition

Condition

Malignant tumors

Classification by specialty

Medicine in general

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study designs to develop a predictive strategy for the detection of the patients with high risk for delirium by analyzing bloods obtained from the patients who are in palliative care wards at the stage before and after the delirium onset.

Basic objectives2

Others

Basic objectives -Others

None

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of factors associated with delirium onset.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients in palliative care unit
2) Patients who are not delirium at the time of hospitalization
3) Patients who can obtain consent form

Key exclusion criteria

1) Patients who are at Delirium at the time of hospitalization
2) Patient judged by the attending physician to be inappropriate

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Okawaki

Organization

Kawasaki Medical School

Division name

Clinical Oncology

Zip code

701-0192

Address

Matsushima 577, Kurashiki, Okayama

TEL

086-462-1111

Email

m.okawaki@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Okawaki

Organization

Kawasaki Medical School

Division name

Clinical Oncology

Zip code

701-0192

Address

Matsushima 577, Kurashiki, Okayama

TEL

086-462-1111

Homepage URL


Email

m.okawaki@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki Medical School

Address

577 Matsushima, Kurashiki, Okayama

Tel

086-462-1111

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 12 Month 20 Day

Date of IRB

2020 Year 02 Month 03 Day

Anticipated trial start date

2020 Year 02 Month 03 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 12 Month 20 Day

Last modified on

2022 Year 09 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044406


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name